Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples